Publications by authors named "Adrien Daniel"

Claim this Profile
D
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.
Leïla Ben Dhia, Mathieu Wemeau, Laurène Fenwarth, Alice Marceau-Renaut, Elise Fournier, Adrien Daniel

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crescentic glomerulonephritis associated with myelodysplatic syndrome and visceral leishmaniasis.
Antoine Decaestecker, Adrien Daniel, Zoé Malbranque, Nicolas Wayolle, Amandine Ydee

J Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia.
Mélinda Dantec, Maxime Dufossé, Augustin Boudry, Elise Fournier, Laure Goursaud, Adrien Daniel

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.
Eléonore Kaphan, François Bettega, Edouard Forcade, Hélène Labussière-Wallet, Nathalie Fegueux, Adrien Daniel

Transplant Cell Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Luis Veloza, Doriane Cavalieri, Edoardo Missiaglia, Albane Ledoux-Pilon, Bettina Bisig, Adrien Daniel

Haematologica· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.
Adrien Daniel, David Ghez, Camille Ravaiau, Doriane Cavalieri, Olivier Tournilhac

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Stephen J F Chong, Mary C Collins, Adrien Daniel

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of double-hit and triple-hit lymphomas: Survival and tolerance data from a retrospective multicenter French study.
Marie-Charlotte Laude, Laure Lebras, Pierre Sesques, Herve Ghesquieres, Simon Favre, Adrien Daniel

Am J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A patient with rheumatoid arthritis presenting a nephrotic syndrome: A case report].
Adrien Daniel, Jean-Baptiste Gibier, Raymond Azar

Nephrol Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multiple myeloma: New criteria for diagnosis and treatment, strong therapeutic hopes].
Salomon Manier, Marie de Charette de la Contrie, Julia Hieulle, Adrien Daniel, Thierry Facon

Presse Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis